Superstring Capital Management’s Xenon Pharmaceuticals XENE Stock Holding History
Bought
Maintained
Sold
Other funds holding XENE
Superstring Capital Management's XENE Position: Q3 2026 in Review
Superstring Capital Management opened a new position in Xenon Pharmaceuticals (XENE) in Q3 2026: 26,496 shares worth $985K. The stake represents 0.49% of the portfolio and ranks #31 among its holdings.
288 funds tracked by Wall St. Rank hold XENE as of Q3 2026.
- Superstring Capital Management held 26,496 shares of Xenon Pharmaceuticals worth $985K as of Q3 2026.
- Xenon Pharmaceuticals was a new Superstring Capital Management position in Q3 2026.
- Xenon Pharmaceuticals made up 0.49% of Superstring Capital Management's portfolio in Q3 2026, its #31 holding.
- 288 funds tracked by Wall St. Rank held Xenon Pharmaceuticals as of Q3 2026.
Based on Superstring Capital Management's 13F filing for Q3 2026, filed 16 Nov 2026.